Even Keel Resurfacing Peel Gel
FDA Label NDC 84234-000
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Personal Day Inc. for the product Even Keel Resurfacing Peel (NDC 84234-000). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding drug facts, active ingredients, purpose, uses, warnings, when using this product, keep out of reach of children., directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Active Ingredients
Salicylic Acid 1.05%
Purpose
Acne treatment
Uses
- Treats acne
- Helps prevent the development of new acne blemishes
Warnings
For external use only
When Using This Product
skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
Keep Out Of Reach Of Children.
If swallowed, get medical help or contact a Poison Control Center immediately.
Directions
- After cleansing, cover the affected area with a thin layer one to two times per week.
- Because excessive drying of the skin may occur, start with one application (weekly), then gradually increase to two times weekly, if needed or as directed by a doctor.
- If bothersome dryness or peeling occurs, reduce application to every other week.
Inactive Ingredients
Water, Lactic Acid, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Polyacrylate Crosspolymer-6, Glycolic Acid, Glycerin, Oryza Sativa (Rice) Powder, Mandelic Acid, Potassium Azeloyl Diglycinate, 1,2-Hexanediol, Caprylyl Glycol, Hydroxyacetophenone, Sodium Hydroxide, Xanthan Gum, Sorbitan Isostearate, Citric Acid, Propanediol, Zinc Hydrolyzed Hyaluronate, t-Butyl Alcohol, Beta-Glucan
Questions Or Comments?
1-888-404-3461
Package Labeling:
* Please review the disclaimer below.